Haffkine Bio-Pharmaceutical Corporation Ltd.
Haffkine Bio-Pharmaceutical Corporation Ltd., commonly referred to as Haffkine, is a prominent player in the biopharmaceutical industry, headquartered in Mumbai, India. Established in 1899, the company has a rich history of innovation and excellence, particularly in the fields of vaccine production and biopharmaceuticals. Haffkine is renowned for its core products, which include vaccines for various infectious diseases, as well as a range of diagnostic kits and therapeutic solutions. The company’s commitment to quality and affordability sets it apart in a competitive market. With a strong presence across India and significant operational reach in international markets, Haffkine has achieved notable milestones, including recognition for its contributions to public health. As a trusted name in the biopharmaceutical sector, Haffkine continues to play a vital role in advancing healthcare solutions.
DitchCarbon Score
How does Haffkine Bio-Pharmaceutical Corporation Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haffkine Bio-Pharmaceutical Corporation Ltd.'s score of 4 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Haffkine Bio-Pharmaceutical Corporation Ltd.'s reported carbon emissions
Haffkine Bio-Pharmaceutical Corporation Ltd., headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many organisations in the biopharmaceutical sector are increasingly focusing on sustainability and reducing their carbon footprints. Haffkine may be expected to align with industry trends towards enhanced environmental responsibility in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haffkine Bio-Pharmaceutical Corporation Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
